Gene Logic K.K. Officially Opens Office in Japan
Local Presence to Meet the Needs of Japanese Pharmaceutical Customers
Gene Logic Inc. announced that it's wholly owned Japan subsidiary, Gene Logic K.K., has officially opened its offices in Japan to more closely provide sales support and customer service to pharmaceutical customers in Japan. The Company has located its offices in downtown Tokyo, hired two technical support managers and retained an executive search firm to find a General Manager for Japan.
As of the most recent quarter, over 30 percent of Gene Logic revenue is from Japanese-headquartered pharmaceutical companies. Japan is the world's second largest pharmaceutical marketplace, in terms of revenue, following the United States.
"Japanese pharmaceutical companies have been the source of many worldwide blockbuster medicines in antibiotic therapy, cardiology and neurology. These global leaders rely on Gene Logic information and services to pursue important innovation," said Mark D. Gessler, president and CEO, Gene Logic, Inc. "With the opening of this office and enhanced local support, we are solidifying our presence in Japan consistent with our strategy to build close, long-standing business relationships with our Japanese pharmaceutical customers. We are committed to helping our customers identify therapeutic possibilities faster and recognize clinical obstacles earlier by using our data and services as a roadmap for better performance."
Other news from the department business & finance
